| Date Filed | Type | Description |
| 08/24/2023 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Sold 25,000 shares
@ $38.7, valued at
$967.5k
|
|
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,475 options to buy
@ $38.96, valued at
$719.8k
|
|
| 05/11/2023 |
4
| Svoronos Dawn (Director) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Bought 15,000 shares
@ $18, valued at
$270k
Disposed of 155,450 options to buy
@ $5.8766, valued at
$913.5k
Acquired 155,450 options to buy
@ $5.8766, valued at
$913.5k
Disposed of 23,243 options to buy
@ $18, valued at
$418.4k
Acquired 23,243 options to buy
@ $18, valued at
$418.4k
|
|
| 05/04/2023 |
4
| Svoronos Dawn (Director) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Granted 23,243 options to buy
@ $18, valued at
$418.4k
|
|
| 05/04/2023 |
3
| Svoronos Dawn (Director) has filed a Form 3 on ACELYRIN, Inc. |
| 10/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 18,000 options to buy
@ $30.11, valued at
$542k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2022 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0.9903, valued at
$39.6k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 30,000 shares
@ $0.8526, valued at
$25.6k
|
|
| 01/11/2022 |
4
| Svoronos Dawn (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 510 shares
@ $38.525, valued at
$19.6k
Granted 3,200 shares
@ $0
Granted 12,000 options to buy
@ $38.1, valued at
$457.2k
|
|
| 06/21/2021 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Sold 1,609 shares
@ $36.54, valued at
$58.8k
Exercised 3,037 restricted stock units
@ $0
Granted 5,600 options to buy
@ $37.09, valued at
$207.7k
Granted 3,600 restricted stock units
@ $0 |
|
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2021 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 10,000 options to buy
@ $18.56, valued at
$185.6k
|
|
| 05/14/2021 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.7, valued at
$148k
|
|
| 04/01/2021 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Bought 20,000 shares
@ $10.0169, valued at
$200.3k
|
|
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.|
Txns:
| Granted 45,000 options to buy
@ $12.82, valued at
$576.9k
|
|
| 12/11/2020 |
3
| Svoronos Dawn (Director) has filed a Form 3 on Adverum Biotechnologies, Inc. |
| 06/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Svoronos Dawn (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Sold 364 shares
@ $48.36, valued at
$17.6k
|
|
| 06/02/2020 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 10,000 options to buy
@ $13.11, valued at
$131.1k
|
|
| 01/31/2020 |
4
| Svoronos Dawn (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 1,650 shares
@ $0
Granted 10,000 options to buy
@ $51.16, valued at
$511.6k
|
|
| 09/18/2019 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 15,000 options to buy
@ $9.44, valued at
$141.6k
|
|
| 06/20/2019 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 7,500 options to buy
@ $56.3, valued at
$422.3k
Granted 4,800 restricted stock units
@ $0 |
|
| 01/24/2019 |
4
| Svoronos Dawn (Director) has filed a Form 4 on PTC THERAPEUTICS, INC.|
Txns:
| Granted 14,000 options to buy
@ $33.02, valued at
$462.3k
|
|
| 12/21/2018 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $38.68, valued at
$1.2M
|
|
| 12/21/2018 |
3
| Svoronos Dawn (Director) has filed a Form 3 on Global Blood Therapeutics, Inc. |
| 12/21/2018 |
4
| Svoronos Dawn (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 3,750 shares
@ $24, valued at
$90k
Disposed/sold 3,300 shares
@ $24, valued at
$79.2k
Disposed/sold 22,500 options to buy
@ $10.81, valued at
$243.2k
Disposed/sold 19,500 options to buy
@ $10.81, valued at
$210.8k
|
|
| 06/05/2018 |
4
| Svoronos Dawn (Director) has filed a Form 4 on Xenon Pharmaceuticals Inc.|
Txns:
| Granted 15,000 options to buy
@ $6.2, valued at
$93k
|
|
|